SciTransfer
Organization

UMWELTBUNDESAMT

Germany's Federal Environment Agency — regulatory science authority for chemical safety, human biomonitoring, and environmental health policy across Europe.

Public authorityenvironmentDE
H2020 projects
16
As coordinator
2
Total EC funding
€13.9M
Unique partners
329
What they do

Their core work

Germany's Federal Environment Agency (UBA) is the country's central authority on environmental and health protection, providing scientific evidence to underpin environmental policy and regulation. In H2020, UBA has been a key player in chemical risk assessment, human biomonitoring, and greenhouse gas monitoring — translating scientific findings into regulatory guidance. They bring a rare combination of regulatory authority and deep scientific capacity, making them essential for projects that need to bridge research results and EU-level policy implementation.

Core expertise

What they specialise in

Persistent and mobile chemical substances (PFAS, microplastics)primary
4 projects

PlasticsFatE, POLYRISK, ZeroPM, and PROMISCES all address micro/nanoplastics, PFAS, or persistent mobile substances in environment and human health.

Soil, sediment, and land-use managementsecondary
2 projects

Coordinated INSPIRATION (strategic research agenda for soil-sediment systems and land take) and participated in PROMISCES (soil-sediment circular economy).

Aquatic ecosystem research infrastructuresecondary
2 projects

Participated in both AQUACOSM and AQUACOSM-plus, supporting Europe's network of mesocosm experimental facilities.

Endocrine disruptor testing and regulationemerging
2 projects

HBM4EU included endocrine disruptor biomarkers, and ERGO specifically targets integrated testing approaches for endocrine disruption aligned with OECD guidelines.

Evolution & trajectory

How they've shifted over time

Early focus
Environmental policy and risk systems
Recent focus
Chemical exposure and human health

In the early H2020 period (2015–2018), UBA's work was broad and policy-oriented: soil and land-use strategy (INSPIRATION), flood risk systems (SYSTEM-RISK), energy efficiency in retail (SuperSmart), and safe-by-design manufacturing (PROSAFE). From 2019 onward, UBA concentrated sharply on chemical safety and human health — microplastics, PFAS, persistent mobile substances, and endocrine disruptors dominate their recent portfolio. The pivot from general environmental policy toward molecular-level health and exposure science is unmistakable, with five of their last six projects focused on chemicals in the human body or environment.

UBA is consolidating as Europe's go-to regulatory science partner for chemical safety, PFAS regulation, and zero-pollution policy — expect them to be central in any Horizon Europe call on safe chemicals or plastics.

Collaboration profile

How they like to work

Role: active_partnerReach: European36 countries collaborated

UBA primarily joins consortia as a participant (13 of 16 projects) rather than leading them, but when they do coordinate — as with HBM4EU — they manage very large pan-European initiatives. With 329 unique partners across 36 countries, they operate as a high-connectivity hub, linking regulatory expertise into diverse research teams. Their role is typically to provide the policy-science interface: they bring regulatory credibility and ensure research outputs can be translated into actionable guidance for policymakers.

UBA has collaborated with 329 distinct partners across 36 countries, giving them one of the broadest networks among German research-regulatory bodies. Their partnerships span from university labs to national environment agencies across the EU, with particularly strong connections in the health-environment nexus.

Why partner with them

What sets them apart

UBA is not a university or private research institute — it is Germany's federal environmental authority, which means it carries regulatory weight that pure research partners cannot offer. For any consortium needing to demonstrate policy relevance or regulatory uptake of results, having UBA on board signals credibility to evaluators and end-users alike. Their dual capacity in both deep scientific analysis (biomonitoring, exposure modeling) and direct policy translation makes them a uniquely valuable bridge between lab findings and EU regulation.

Notable projects

Highlights from their portfolio

  • HBM4EU
    Coordinated by UBA with €11.1M EC funding — the largest human biomonitoring initiative in Europe, establishing reference values for chemical exposure across EU populations.
  • INSPIRATION
    UBA-coordinated strategic research agenda for soil and land use across Europe, demonstrating their capacity to set science-policy priorities at continental scale.
  • ZeroPM
    Targets zero pollution from persistent mobile substances — directly aligned with the EU Green Deal's zero-pollution ambition and UBA's regulatory mandate on chemical safety.
Cross-sector capabilities
Health — chemical exposure, biomonitoring, endocrine disruptors, microplastics toxicologyManufacturing — safe-by-design chemicals, circular economy for industrial substancesEnergy — greenhouse gas monitoring and verification, emissions inventoriesFood — PFAS and persistent chemicals in food chains and water reuse
Analysis note: UBA's profile is exceptionally well-documented across 16 projects with clear thematic clustering. The HBM4EU coordination (€11.1M) represents the vast majority of their total EC funding, which slightly skews the funding average — most of their participations are in the €100K–€600K range typical of a contributing partner rather than a lead.